<DOC>
	<DOC>NCT02931266</DOC>
	<brief_summary>Prospective, multicenter non comparative and observational study (post-market clinical follow-up).</brief_summary>
	<brief_title>PASS MIS® Post-market Clinical Follow-up</brief_title>
	<detailed_description>Patients operated with PASS MIS® manufactured by MEDICREA® INTERNATIONAL between July 2016 and July 2017. The inclusion period will be 12 months and the follow-up 24 months</detailed_description>
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<criteria>Patient which need to be operated to treat a fracture at the lumbar and/or thoracic spine with the PASS MIS® device from MEDICREA® Patient &gt; 18years Patient with a mature skeleton Patient able to understand the protocol and the planning visit Patient able to complete a selfadministered questionnaire Patient who have signed the informed consent form Patient presenting other medical indication than thoracolumbar fracture Patient unable or who refuse to sign an informed consent form Patient unable to complete a selfadministered questionnaire Patient judged as noncompliant by the investigator or not able to come back for followup visits Patient who need to receive or who received an open procedure Patient who has been not implanted with the PASS MIS® system Pregnant women or intending to get pregnant within the next 2 years after the surgery Patient with contraindications to do radiographies Local infectious state Allergy or intolerance to the materials, suspected or known Any contraindications present in the notice of the product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>